Selvina Tablet (Terbinafine Hydrochloride)

Adult dose

As terbinafine: 125 mg once, administered twice daily, or 250 mg once daily. The duration of treatment varies according to the condition: 1) Dermatophyte infections - Tinea pedis (interdigital type, plantar type/mocha type): 2 to 6 weeks - Tinea corporis: 2 to 4 weeks - Tinea cruris: 2 to 4 weeks 2) Onychomycosis - Typically administered for 6 weeks to 3 months. - The duration of treatment can be shortened to less than 3 months for toenail infections or in younger patients. The treatment duration for toenail infections is usually sufficient at 3 months, but some patients may require more than 6 months. For patients with slow nail growth, the treatment period may be prolonged.

Child dose

Administer to children aged 2 years and older. 1) Children weighing less than 20 kg (under 5 years): 62.5 mg once daily. 2) Children weighing 20–40 kg (5 to 12 years): 125 mg once daily.

This drug should generally not be used in patients with chronic liver disease or active liver disease. A liver function test must be performed before administration, and it should be monitored regularly during treatment, with immediate cessation of use if any abnormal signs are detected. Symptoms that may indicate liver dysfunction include nausea, loss of appetite, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, diarrhea, etc. If any of these symptoms occur, the doctor should be informed immediately. Additionally, hepatic failure can rarely occur, so if liver damage is suspected, the medication must be stopped immediately. This medication should not be administered to patients who are hypersensitive to its components, those with chronic or active liver disease, blood disorders, severe renal failure, nursing mothers, or infants under 2 years of age. Since it contains lactose, patients with lactose intolerance or related genetic disorders should also refrain from taking it. Caution is advised when administering to patients with reduced kidney function, the elderly (aged 65 or older), or children weighing less than 20 kg. Serious skin reactions may rarely occur, so if a rash or abnormal symptoms develop, use should be discontinued immediately. Patients with psoriasis or systemic lupus erythematosus should be particularly vigilant when using this medication. During treatment with this drug, liver function, blood tests, skin condition, etc., should be monitored regularly, and if abnormal symptoms appear, consultation with a doctor should occur immediately. Patients should be cautious while driving or operating machinery, as symptoms such as dizziness may occur. This medication may interact with other drugs, particularly those affecting liver metabolism, so consultation with a doctor or pharmacist is recommended if taking other medications. When used in conjunction with oral contraceptives, menstrual irregularities may occur, so caution is advised. Safety during pregnancy has not been established, thus pregnant women or those who might become pregnant should use it cautiously, and breastfeeding mothers should avoid using it. In case of overdose, symptoms such as headache, nausea, abdominal pain, dizziness, etc., may appear, and appropriate treatment should be administered based on the symptoms. This medication should be kept out of reach of children, protected from sunlight, and stored at room temperature. Transferring to another container is not advisable as it may compromise quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, rash, blisters, skin peeling, pain in oral/ocular mucosa, jaundice, liver failure, hepatitis, cholestasis, severe skin abnormal reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), dyspnea, asthma attacks, severe neurological symptoms (headache, seizures, confusion, visual disturbances, paralysis), significant reduction in urine output, severe edema, blood abnormalities

Mild side effects

Fatigue, nausea, loss of appetite, vomiting, diarrhea, abdominal pain, headache, dizziness, rash, itching, photosensitivity reactions, taste disorders, drowsiness, insomnia, anxiety, depression, hypotension, increase in serum cholesterol and triglycerides, menstrual irregularities, thrombocytopenia, anemia, visual disturbances, tinnitus, lethargy, weight loss, glossitis, tongue discoloration, palpitations, edema, fever, musculoskeletal pain, and weakness, sensory abnormalities, drowsiness, insomnia, BUN

This medication should be stored in a tightly closed container to avoid exposure to air and kept at a temperature between 1 and 30 degrees Celsius. Proper storage is essential to maintain the efficacy of the drug and prevent deterioration.

Appearance

White to off-white round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle